NCT02393937

A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 963 (actual)
• Sponsor: bioRASI, LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the efficacy of two Metronidazole Gels 1%, in the treatment of Rosacea.

Conditions

• Papulopustular Rosacea
• Erythematotelangiectatic Rosacea

Interventions

Type	Name	Description
DRUG	Reference: Metronidazole Gel 1%	Participants are assigned to one of three groups in parallel for the duration of the study
DRUG	Test: Metronidazole Gel 1%	Participants are assigned to one of three groups in parallel for the duration of the study
DRUG	Placebo Gel	Participants are assigned to one of three groups in parallel for the duration of the study

Timeline

• Start date: 2015-02-01
• Primary completion: 2015-07-01
• Completion: 2015-10-01
• First posted: 2015-03-20
• Last updated: 2020-09-03

Locations

27 sites across 1 country: United States